1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Parkinson's Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Carbidopa/Levodopa 1.2.3 Dopamine Receptor Agonists 1.2.4 MAO-Inhibitors 1.3 Market by Application 1.3.1 Global Parkinson's Disease Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Parkinson's Disease Market Perspective (2016-2027) 2.2 Parkinson's Disease Growth Trends by Regions 2.2.1 Parkinson's Disease Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Parkinson's Disease Historic Market Share by Regions (2016-2021) 2.2.3 Parkinson's Disease Forecasted Market Size by Regions (2022-2027) 2.3 Parkinson's Disease Industry Dynamic 2.3.1 Parkinson's Disease Market Trends 2.3.2 Parkinson's Disease Market Drivers 2.3.3 Parkinson's Disease Market Challenges 2.3.4 Parkinson's Disease Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Parkinson's Disease Players by Revenue 3.1.1 Global Top Parkinson's Disease Players by Revenue (2016-2021) 3.1.2 Global Parkinson's Disease Revenue Market Share by Players (2016-2021) 3.2 Global Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Parkinson's Disease Revenue 3.4 Global Parkinson's Disease Market Concentration Ratio 3.4.1 Global Parkinson's Disease Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Revenue in 2020 3.5 Parkinson's Disease Key Players Head office and Area Served 3.6 Key Players Parkinson's Disease Product Solution and Service 3.7 Date of Enter into Parkinson's Disease Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Parkinson's Disease Breakdown Data by Type 4.1 Global Parkinson's Disease Historic Market Size by Type (2016-2021) 4.2 Global Parkinson's Disease Forecasted Market Size by Type (2022-2027) 5 Parkinson's Disease Breakdown Data by Application 5.1 Global Parkinson's Disease Historic Market Size by Application (2016-2021) 5.2 Global Parkinson's Disease Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Parkinson's Disease Market Size (2016-2027) 6.2 North America Parkinson's Disease Market Size by Type 6.2.1 North America Parkinson's Disease Market Size by Type (2016-2021) 6.2.2 North America Parkinson's Disease Market Size by Type (2022-2027) 6.2.3 North America Parkinson's Disease Market Size by Type (2016-2027) 6.3 North America Parkinson's Disease Market Size by Application 6.3.1 North America Parkinson's Disease Market Size by Application (2016-2021) 6.3.2 North America Parkinson's Disease Market Size by Application (2022-2027) 6.3.3 North America Parkinson's Disease Market Size by Application (2016-2027) 6.4 North America Parkinson's Disease Market Size by Country 6.4.1 North America Parkinson's Disease Market Size by Country (2016-2021) 6.4.2 North America Parkinson's Disease Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Parkinson's Disease Market Size (2016-2027) 7.2 Europe Parkinson's Disease Market Size by Type 7.2.1 Europe Parkinson's Disease Market Size by Type (2016-2021) 7.2.2 Europe Parkinson's Disease Market Size by Type (2022-2027) 7.2.3 Europe Parkinson's Disease Market Size by Type (2016-2027) 7.3 Europe Parkinson's Disease Market Size by Application 7.3.1 Europe Parkinson's Disease Market Size by Application (2016-2021) 7.3.2 Europe Parkinson's Disease Market Size by Application (2022-2027) 7.3.3 Europe Parkinson's Disease Market Size by Application (2016-2027) 7.4 Europe Parkinson's Disease Market Size by Country 7.4.1 Europe Parkinson's Disease Market Size by Country (2016-2021) 7.4.2 Europe Parkinson's Disease Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Parkinson's Disease Market Size (2016-2027) 8.2 Asia-Pacific Parkinson's Disease Market Size by Type 8.2.1 Asia-Pacific Parkinson's Disease Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Parkinson's Disease Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Parkinson's Disease Market Size by Type (2016-2027) 8.3 Asia-Pacific Parkinson's Disease Market Size by Application 8.3.1 Asia-Pacific Parkinson's Disease Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Parkinson's Disease Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Parkinson's Disease Market Size by Application (2016-2027) 8.4 Asia-Pacific Parkinson's Disease Market Size by Region 8.4.1 Asia-Pacific Parkinson's Disease Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Parkinson's Disease Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Parkinson's Disease Market Size (2016-2027) 9.2 Latin America Parkinson's Disease Market Size by Type 9.2.1 Latin America Parkinson's Disease Market Size by Type (2016-2021) 9.2.2 Latin America Parkinson's Disease Market Size by Type (2022-2027) 9.2.3 Latin America Parkinson's Disease Market Size by Type (2016-2027) 9.3 Latin America Parkinson's Disease Market Size by Application 9.3.1 Latin America Parkinson's Disease Market Size by Application (2016-2021) 9.3.2 Latin America Parkinson's Disease Market Size by Application (2022-2027) 9.3.3 Latin America Parkinson's Disease Market Size by Application (2016-2027) 9.4 Latin America Parkinson's Disease Market Size by Country 9.4.1 Latin America Parkinson's Disease Market Size by Country (2016-2021) 9.4.2 Latin America Parkinson's Disease Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Parkinson's Disease Market Size (2016-2027) 10.2 Middle East & Africa Parkinson's Disease Market Size by Type 10.2.1 Middle East & Africa Parkinson's Disease Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Parkinson's Disease Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Parkinson's Disease Market Size by Type (2016-2027) 10.3 Middle East & Africa Parkinson's Disease Market Size by Application 10.3.1 Middle East & Africa Parkinson's Disease Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Parkinson's Disease Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Parkinson's Disease Market Size by Application (2016-2027) 10.4 Middle East & Africa Parkinson's Disease Market Size by Country 10.4.1 Middle East & Africa Parkinson's Disease Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Parkinson's Disease Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Teva 11.1.1 Teva Company Details 11.1.2 Teva Business Overview 11.1.3 Teva Parkinson's Disease Introduction 11.1.4 Teva Revenue in Parkinson's Disease Business (2016-2021) 11.1.5 Teva Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Parkinson's Disease Introduction 11.2.4 Novartis Revenue in Parkinson's Disease Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 GSK 11.3.1 GSK Company Details 11.3.2 GSK Business Overview 11.3.3 GSK Parkinson's Disease Introduction 11.3.4 GSK Revenue in Parkinson's Disease Business (2016-2021) 11.3.5 GSK Recent Development 11.4 AbbVie 11.4.1 AbbVie Company Details 11.4.2 AbbVie Business Overview 11.4.3 AbbVie Parkinson's Disease Introduction 11.4.4 AbbVie Revenue in Parkinson's Disease Business (2016-2021) 11.4.5 AbbVie Recent Development 11.5 Merck 11.5.1 Merck Company Details 11.5.2 Merck Business Overview 11.5.3 Merck Parkinson's Disease Introduction 11.5.4 Merck Revenue in Parkinson's Disease Business (2016-2021) 11.5.5 Merck Recent Development 11.6 Boehringer Ingelheim 11.6.1 Boehringer Ingelheim Company Details 11.6.2 Boehringer Ingelheim Business Overview 11.6.3 Boehringer Ingelheim Parkinson's Disease Introduction 11.6.4 Boehringer Ingelheim Revenue in Parkinson's Disease Business (2016-2021) 11.6.5 Boehringer Ingelheim Recent Development 11.7 Amneal + Impax 11.7.1 Amneal + Impax Company Details 11.7.2 Amneal + Impax Business Overview 11.7.3 Amneal + Impax Parkinson's Disease Introduction 11.7.4 Amneal + Impax Revenue in Parkinson's Disease Business (2016-2021) 11.7.5 Amneal + Impax Recent Development 11.8 Lundbeck 11.8.1 Lundbeck Company Details 11.8.2 Lundbeck Business Overview 11.8.3 Lundbeck Parkinson's Disease Introduction 11.8.4 Lundbeck Revenue in Parkinson's Disease Business (2016-2021) 11.8.5 Lundbeck Recent Development 11.9 Sun Pharma 11.9.1 Sun Pharma Company Details 11.9.2 Sun Pharma Business Overview 11.9.3 Sun Pharma Parkinson's Disease Introduction 11.9.4 Sun Pharma Revenue in Parkinson's Disease Business (2016-2021) 11.9.5 Sun Pharma Recent Development 11.10 Wockhardt 11.10.1 Wockhardt Company Details 11.10.2 Wockhardt Business Overview 11.10.3 Wockhardt Parkinson's Disease Introduction 11.10.4 Wockhardt Revenue in Parkinson's Disease Business (2016-2021) 11.10.5 Wockhardt Recent Development 11.11 UCB 11.11.1 UCB Company Details 11.11.2 UCB Business Overview 11.11.3 UCB Parkinson's Disease Introduction 11.11.4 UCB Revenue in Parkinson's Disease Business (2016-2021) 11.11.5 UCB Recent Development 11.12 Bausch Health 11.12.1 Bausch Health Company Details 11.12.2 Bausch Health Business Overview 11.12.3 Bausch Health Parkinson's Disease Introduction 11.12.4 Bausch Health Revenue in Parkinson's Disease Business (2016-2021) 11.12.5 Bausch Health Recent Development 11.13 Acadia 11.13.1 Acadia Company Details 11.13.2 Acadia Business Overview 11.13.3 Acadia Parkinson's Disease Introduction 11.13.4 Acadia Revenue in Parkinson's Disease Business (2016-2021) 11.13.5 Acadia Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Parkinson's Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Carbidopa/Levodopa Table 3. Key Players of Dopamine Receptor Agonists Table 4. Key Players of MAO-Inhibitors Table 5. Global Parkinson's Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Parkinson's Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Parkinson's Disease Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Parkinson's Disease Market Share by Regions (2016-2021) Table 9. Global Parkinson's Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Parkinson's Disease Market Share by Regions (2022-2027) Table 11. Parkinson's Disease Market Trends Table 12. Parkinson's Disease Market Drivers Table 13. Parkinson's Disease Market Challenges Table 14. Parkinson's Disease Market Restraints Table 15. Global Parkinson's Disease Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Parkinson's Disease Market Share by Players (2016-2021) Table 17. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease as of 2020) Table 18. Ranking of Global Top Parkinson's Disease Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Parkinson's Disease Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Parkinson's Disease Product Solution and Service Table 22. Date of Enter into Parkinson's Disease Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Parkinson's Disease Market Size by Type (2016-2021) (US$ Million) Table 25. Global Parkinson's Disease Revenue Market Share by Type (2016-2021) Table 26. Global Parkinson's Disease Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Parkinson's Disease Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Parkinson's Disease Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Parkinson's Disease Revenue Market Share by Application (2016-2021) Table 30. Global Parkinson's Disease Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Parkinson's Disease Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Parkinson's Disease Market Size by Type (2016-2021) (US$ Million) Table 33. North America Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Parkinson's Disease Market Size by Application (2016-2021) (US$ Million) Table 35. North America Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Parkinson's Disease Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Parkinson's Disease Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Parkinson's Disease Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Parkinson's Disease Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Parkinson's Disease Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Parkinson's Disease Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Parkinson's Disease Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Parkinson's Disease Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Parkinson's Disease Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Parkinson's Disease Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million) Table 62. Teva Company Details Table 63. Teva Business Overview Table 64. Teva Parkinson's Disease Product Table 65. Teva Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 66. Teva Recent Development Table 67. Novartis Company Details Table 68. Novartis Business Overview Table 69. Novartis Parkinson's Disease Product Table 70. Novartis Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 71. Novartis Recent Development Table 72. GSK Company Details Table 73. GSK Business Overview Table 74. GSK Parkinson's Disease Product Table 75. GSK Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 76. GSK Recent Development Table 77. AbbVie Company Details Table 78. AbbVie Business Overview Table 79. AbbVie Parkinson's Disease Product Table 80. AbbVie Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 81. AbbVie Recent Development Table 82. Merck Company Details Table 83. Merck Business Overview Table 84. Merck Parkinson's Disease Product Table 85. Merck Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 86. Merck Recent Development Table 87. Boehringer Ingelheim Company Details Table 88. Boehringer Ingelheim Business Overview Table 89. Boehringer Ingelheim Parkinson's Disease Product Table 90. Boehringer Ingelheim Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 91. Boehringer Ingelheim Recent Development Table 92. Amneal + Impax Company Details Table 93. Amneal + Impax Business Overview Table 94. Amneal + Impax Parkinson's Disease Product Table 95. Amneal + Impax Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 96. Amneal + Impax Recent Development Table 97. Lundbeck Company Details Table 98. Lundbeck Business Overview Table 99. Lundbeck Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 100. Lundbeck Recent Development Table 101. Sun Pharma Company Details Table 102. Sun Pharma Business Overview Table 103. Sun Pharma Parkinson's Disease Product Table 104. Sun Pharma Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 105. Sun Pharma Recent Development Table 106. Wockhardt Company Details Table 107. Wockhardt Business Overview Table 108. Wockhardt Parkinson's Disease Product Table 109. Wockhardt Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 110. Wockhardt Recent Development Table 111. UCB Company Details Table 112. UCB Business Overview Table 113. UCB Parkinson's Disease Product Table 114. UCB Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 115. UCB Recent Development Table 116. Bausch Health Company Details Table 117. Bausch Health Business Overview Table 118. Bausch Health Parkinson's Disease Product Table 119. Bausch Health Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 120. Bausch Health Recent Development Table 121. Acadia Company Details Table 122. Acadia Business Overview Table 123. Acadia Parkinson's Disease Product Table 124. Acadia Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million) Table 125. Acadia Recent Development Table 126. Research Programs/Design for This Report Table 127. Key Data Information from Secondary Sources Table 128. Key Data Information from Primary Sources List of Figures Figure 1. Global Parkinson's Disease Market Share by Type: 2020 VS 2027 Figure 2. Carbidopa/Levodopa Features Figure 3. Dopamine Receptor Agonists Features Figure 4. MAO-Inhibitors Features Figure 5. Global Parkinson's Disease Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Parkinson's Disease Report Years Considered Figure 9. Global Parkinson's Disease Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Parkinson's Disease Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Parkinson's Disease Market Share by Regions: 2020 VS 2027 Figure 12. Global Parkinson's Disease Market Share by Regions (2022-2027) Figure 13. Global Parkinson's Disease Market Share by Players in 2020 Figure 14. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Parkinson's Disease Revenue in 2020 Figure 16. Global Parkinson's Disease Revenue Market Share by Type (2016-2021) Figure 17. Global Parkinson's Disease Revenue Market Share by Type (2022-2027) Figure 18. North America Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Parkinson's Disease Market Share by Type (2016-2027) Figure 20. North America Parkinson's Disease Market Share by Application (2016-2027) Figure 21. North America Parkinson's Disease Market Share by Country (2016-2027) Figure 22. United States Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Parkinson's Disease Market Share by Type (2016-2027) Figure 26. Europe Parkinson's Disease Market Share by Application (2016-2027) Figure 27. Europe Parkinson's Disease Market Share by Country (2016-2027) Figure 28. Germany Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Parkinson's Disease Market Share by Type (2016-2027) Figure 36. Asia-Pacific Parkinson's Disease Market Share by Application (2016-2027) Figure 37. Asia-Pacific Parkinson's Disease Market Share by Region (2016-2027) Figure 38. China Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Parkinson's Disease Market Share by Type (2016-2027) Figure 46. Latin America Parkinson's Disease Market Share by Application (2016-2027) Figure 47. Latin America Parkinson's Disease Market Share by Country (2016-2027) Figure 48. Mexico Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Parkinson's Disease Market Share by Type (2016-2027) Figure 52. Middle East & Africa Parkinson's Disease Market Share by Application (2016-2027) Figure 53. Middle East & Africa Parkinson's Disease Market Share by Country (2016-2027) Figure 54. Turkey Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Teva Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 58. Novartis Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 59. GSK Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 60. AbbVie Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 61. Merck Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 62. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 63. Amneal + Impax Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 64. Lundbeck Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 65. Sun Pharma Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 66. Wockhardt Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 67. UCB Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 68. Bausch Health Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 69. Acadia Revenue Growth Rate in Parkinson's Disease Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Teva Novartis GSK AbbVie Merck Boehringer Ingelheim Amneal + Impax Lundbeck Sun Pharma Wockhardt UCB Bausch Health Acadia